SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060200
Filing Date
2023-11-07
Accepted
2023-11-07 16:00:33
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20230930.htm   iXBRL 10-Q 1920472
2 EX-31.1 vor-ex31_1.htm EX-31.1 18199
3 EX-31.2 vor-ex31_2.htm EX-31.2 18203
4 EX-32.1 vor-ex32_1.htm EX-32.1 20877
  Complete submission text file 0000950170-23-060200.txt   6757163

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20230930_lab.xml EX-101.LAB 341523
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20230930_def.xml EX-101.DEF 125332
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20230930.xsd EX-101.SCH 41700
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20230930_pre.xml EX-101.PRE 233427
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20230930_cal.xml EX-101.CAL 40285
52 EXTRACTED XBRL INSTANCE DOCUMENT vor-20230930_htm.xml XML 1284752
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 231383530
SIC: 2836 Biological Products, (No Diagnostic Substances)